Literature DB >> 11353443

Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2.

R M Frieboes1, H W Moises, W F Gattaz, L Yang, T Li, X Liu, P Vetter, F Macciardi, H G Hwu, F Henn.   

Abstract

The well-established role of genetic factors in the etiology of schizophrenia together with reports of allelic association with cPLA2, a phospholipase-A(2) gene, a reported increase of phospholipase-A(2) activity, and the phospholipase-A(2) hypothesis of Horrobin et al. [1995: Med Hypotheses 45:605-613] strongly support cPLA2 (PLA2G4A) and sPLA2 (PLA2G1B) as candidate genes for schizophrenia. In search for allelic association between these phospholipase-A(2) genes and schizophrenia, two samples of Chinese and European origins, in total 328 unrelated schizophrenic patients and their parents, were investigated using Falk and Rubinstein's haplotype relative risk method. Both genes showed marginally significant evidence for association in the total sample (P <or= 0.05), which, however, did not survive the Bonferroni correction for multiple testing. In conclusion, our results do not provide support for the phospholipase-A(2) hypothesis of schizophrenia. Additional studies will be necessary to rule out a possible confounding effect of niacin sensitivity as postulated by Hudson et al. [1999: Biol Psychiatr 46:401-405]. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353443

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  cPLA2 is protective against COX inhibitor-induced intestinal damage.

Authors:  David C Montrose; Krishna Kadaveru; Jillian N M Ilsley; Sierra H Root; Thiruchanduri V Rajan; Manish Ramesh; Frank C Nichols; Bruce T Liang; Dmitry Sonin; Arthur R Hand; Simona Zarini; Robert C Murphy; Glenn S Belinsky; Masako Nakanishi; Daniel W Rosenberg
Journal:  Toxicol Sci       Date:  2010-06-18       Impact factor: 4.849

2.  Association between BanI genotype and increased phospholipase A2 activity in schizophrenia.

Authors:  Nadia R Barbosa; Ricardo M Junqueira; Homero P Vallada; Wagner F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-07-14       Impact factor: 5.270

3.  Re-analysis of genetic polymorphism data supports a relationship between schizophrenia and microsatellite variability in PLA2G4A.

Authors:  Craig J Hudson; Justin X G Zhu; Alexandra M Durocher
Journal:  Psychiatr Genet       Date:  2021-06-01       Impact factor: 2.458

4.  Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China.

Authors:  Guang Yang; Hongqin Xu; Huiping Zhang; Qiong Yu; Yanhua Wu; Jieping Shi; Wenwang Rao; Yueyue You; Changgui Kou; Yaqin Yu
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

Review 5.  Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia.

Authors:  Sabrina H Ansarey
Journal:  Front Psychiatry       Date:  2021-11-30       Impact factor: 4.157

6.  Genetic polymorphism data support a relationship between schizophrenia and microsatellite variability in PLA2G4A in Northern Europeans not Han Chinese.

Authors:  Craig J Hudson; Adam M R Groh; Fabio Macciardi; Rhys C Hudson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2021-12-09       Impact factor: 3.358

7.  Increased PLA2 activity in individuals at ultra-high risk for psychosis.

Authors:  Leda L Talib; Alana C Costa; Helena P G Joaquim; Cícero A C Pereira; Martinus T Van de Bilt; Alexandre A Loch; Wagner F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-03-06       Impact factor: 5.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.